Abstract 6606: Develop dual-targeted CAR-T cells to achieve RCC curesYufei Wang, Wayne A. Marasco, Marion Grimaud et al.|Cancer Research|2020Cited by 3
Abstract 62: Development of dual-targeted fine-tuned immune restoring (DFIR) CAR T cell therapy for clear cell renal cell carcinoma (ccRCC)Yufei Wang, Wayne A. Marasco, Alicia Buck et al.|Cancer Research|2021Cited by 3
295 Affinity fine-tuning anti-CAIX CAR-T cells mitigate on-target off-tumor side effectsYufei Wang, Wayne A. Marasco, David Braun et al.|Regular and Young Investigator Award Abstracts|2022Cited by 3